All Comments by Paul Coleman

  1. Dephosphorylation of tau during transient forebrain ischemia in the rat.
  2. Striation is the characteristic neuritic abnormality in Alzheimer disease.
  3. Age-related alteration of PKC, a key enzyme in memory processes: physiological and pathological examples.
  4. Vulnerability of small GABAergic neurons to human beta-amyloid pentapeptide.
  5. Free D- and L-amino acids in ventricular cerebrospinal fluid from Alzheimer and normal subjects.
  6. Variation in hippocampal neuron number with age and brain volume.
  7. High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes.
  8. Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type.
  9. Physostigmine results in an increased decrement in brain glucose consumption in Alzheimer's disease.
  10. An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease.
  11. Cleavage of Alzheimer's amyloid precursor protein (APP) by secretases occurs after O-glycosylation of APP in the protein secretory pathway. Identification of intracellular compartments in which APP cleavage occurs without using toxic agents that interfere
  12. Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type.
  13. DNA replication precedes neuronal cell death in Alzheimer's disease.
  14. Link Between Education Level and AD Risk Strengthened